Company Profile

Cytex Therapeutics Inc
Profile last edited on: 1/28/2019      CAGE: 4GT70      UEI: G9RMDCWJYGL3

Business Identifier: Bio-artificial devices for orthopedic diseases
Year Founded
2006
First Award
2007
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2608 Erwin Road Suite 19a
Durham, NC 27705
   (919) 912-9839
   cestes@cytextherapeutics.com
   www.cytextherapeutics.com
Location: Single
Congr. District: 04
County: Durham

Public Profile

Cytex Therapeutics develops bio-artificial devices to treat orthopaedic diseases and improve quality of life for patients. It develops a bio-artificial bone and cartilage composite derived from a patient's own cells that is implanted to resurface a patient's arthritic hip joint and provide relief for patients with end-stage arthritis.Cytex’s bio-artificial cartilage mimics the mechanical and biological properties of natural cartilage. Cytex has two products currently in pre-clinical in-vivo studies.Cytex is also conducting research to develop applications for tendon injuries and defects.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NIH $4,773,722
Project Title: Cartilage Regeneration with Tunable Inflammation Resistance
2023 2 NIH $2,431,957
Project Title: Unicondylar Resurfacing in an Ovine Osteoarthritis Disease Model
2021 2 NIH $1,679,033
Project Title: A Treatment Paradigm for Femoracetabular Impingement (FAI)
2019 1 NIH $169,570
Project Title: Regenerative Rotator Cuff Repair in a Clinically Relevant Chronic Disease Model
2019 2 NIH $2,725,093
Project Title: Functional Tissue Engineering for Cartilage Repair

Key People / Management

  Farshid Guilak -- President

  Jeremiah Easley

  Geoffrey R Erickson

  Bradley T Estes -- Vice President, Research and Development

  Christine Estes -- Director of Business Operations

  Lisa E Freed

  Wolfgang B Liedtke

  Franklin T Moutos -- Vice President, Technology Development

  Vincent P Willard